サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1769935

顔用注射剤の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)

Facial Injectables Market (Product Type: Dermal Fillers, Botulinum Toxin, Platelet-Rich Plasma, Deoxycholic Acid, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 213 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
顔用注射剤の世界市場：産業分析、市場規模・シェア・成長・動向・予測 (2025年～2035年)
出版日: 2025年05月06日
発行: Transparency Market Research
ページ情報: 英文 213 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

顔用注射剤市場 - 分析範囲

TMRの調査レポート「世界の顔用注射剤市場」は、2025年から2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年から2035年までの世界の顔用注射剤市場の収益と予測を提供します。また、2025年から2035年までの世界の顔用注射剤市場の複合年間成長率（CAGR、%）も掲載しています。

当レポートは広範な調査を経て作成されています。一次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、顔用注射剤市場を推察しました。

市場概況
市場規模（2024年） 103億米ドル
市場規模（2035年） 270億米ドル
CAGR 9.2%

当レポートでは、世界の顔用注射剤市場の競合情勢について分析しています。世界の顔用注射剤市場で事業を展開する主要企業が特定され、各企業がさまざまな属性でプロファイルされています。企業概要・財務状況・最新動向・SWOTが、当レポートで紹介されている世界の顔用注射剤市場における各企業の属性です。

目次

第1章 序文

第2章 前提条件と分析手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の顔用注射剤市場の分析と予測（2020年～2035年）

第5章 主要洞察

  • 主要な業界イベント（事業提携・協力、製品承認、企業合併・買収 (M&A) ）
  • 製品/ブランド分析
  • 価格分析
  • 技術進歩
  • PESTEL分析
  • 主要国・地域別の規制シナリオ
  • ポーターのファイブフォース分析
  • 主要国別の償還シナリオ
  • エンドユーザーにとっての主要な購入指標
  • 新規市場参入者のための市場開拓戦略

第6章 世界市場の分析と予測：製品種類別

  • イントロダクション・定義
  • 主な分析結果/動向
  • 市場予測：製品種類別（金額ベース、2020～2035年）
    • 皮膚充填剤
      • ヒアルロン酸（HA）
      • カルシウムヒドロキシアパタイト（CaHA）
      • ポリL乳酸（PLLA）
      • ポリメチルメタクリレート（PMMA）
      • その他
    • ボツリヌス毒素
    • 多血小板血漿（PRP）
    • デオキシコール酸
    • その他
  • 市場の魅力分析：製品種類別

第7章 世界市場の分析と予測：性別

  • イントロダクション・定義
  • 主な分析結果/動向
  • 市場予測：性別（金額ベース、2020～2035年）
    • 男性
    • 女性
  • 市場の魅力分析：性別

第8章 世界市場の分析と予測：用途別

  • イントロダクション・定義
  • 主な分析結果/動向
  • 市場予測：用途別（金額ベース、2020～2035年）
    • フェイスライン修正
    • 唇の増大
    • 傷跡治療
    • フェイスリフト
    • 顔のボリュームアップ
    • その他
  • 市場の魅力分析：用途別

第9章 世界市場の分析と予測：エンドユーザー別

  • イントロダクション・定義
  • 主な分析結果/動向
  • 市場予測：エンドユーザー別（金額ベース、2020～2035年）
    • 病院
    • 皮膚科クリニック
    • 医療スパ
    • その他
  • 市場の魅力分析：エンドユーザー別

第10章 世界市場の分析と予測：地域別

  • 主な分析結果
  • 市場予測：地域別（金額ベース、2020～2035年）
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東・アフリカ市場の分析と予測

第16章 競合情勢

  • 市場企業・競合マトリックス（企業の階層別・規模別）
  • 市場シェア分析：企業別（2024年）
  • 企業プロファイル
    • AbbVie Inc.（Allergan Aesthetics）
    • Anika Therapeutics, Inc.
    • Bioplus Co., Ltd.
    • BIOXIS Pharmaceuticals
    • Bloomage Biotech Co., Ltd
    • Galderma
    • Sinclair Pharma
    • Revance Therapeutics, Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Prollenium Medical Technologies Inc.
    • Teoxane SA
    • Croma-Pharma GmbH
    • Fidia Pharma USA Inc.
    • Tiger Aesthetics Medical, LLC
図表

List of Tables

  • Table 01: Global Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 03: Global Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 04: Global Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Facial Injectables Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Facial Injectables Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 09: North America Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 10: North America Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 11: North America Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 12: North America Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 15: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 16: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 17: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 18: Europe Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 20: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 21: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 22: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 23: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 24: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 27: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 28: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 29: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 32: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 33: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 34: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 35: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 36: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Facial Injectables Market Revenue (US$ Bn), by Dermal Fillers, 2020 to 2035
  • Figure 04: Global Facial Injectables Market Revenue (US$ Bn), by Botulinum Toxin, 2020 to 2035
  • Figure 05: Global Facial Injectables Market Revenue (US$ Bn), by Platelet-Rich Plasma (PRP), 2020 to 2035
  • Figure 06: Global Facial Injectables Market Revenue (US$ Bn), by Deoxycholic Acid, 2020 to 2035
  • Figure 07: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 08: Global Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 09: Global Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 10: Global Facial Injectables Market Revenue (US$ Bn), by Male, 2020 to 2035
  • Figure 11: Global Facial Injectables Market Revenue (US$ Bn), by Female, 2020 to 2035
  • Figure 12: Global Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 13: Global Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 14: Global Facial Injectables Market Revenue (US$ Bn), by Facial Line Correction, 2020 to 2035
  • Figure 15: Global Facial Injectables Market Revenue (US$ Bn), by Lip Augmentation, 2020 to 2035
  • Figure 16: Global Facial Injectables Market Revenue (US$ Bn), by Scar Treatment, 2020 to 2035
  • Figure 17: Global Facial Injectables Market Revenue (US$ Bn), by Face Lift, 2020 to 2035
  • Figure 18: Global Facial Injectables Market Revenue (US$ Bn), by Facial Volume Enhancement, 2020 to 2035
  • Figure 19: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 20: Global Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 21: Global Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 22: Global Facial Injectables Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
  • Figure 23: Global Facial Injectables Market Revenue (US$ Bn), by Dermatology Clinics, 2020 to 2035
  • Figure 24: Global Facial Injectables Market Revenue (US$ Bn), by MedSpas, 2020 to 2035
  • Figure 25: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 26: Global Facial Injectables Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Facial Injectables Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 28: North America Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: North America Facial Injectables Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America Facial Injectables Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 31: North America Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 32: North America Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 33: North America Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 34: North America Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 35: North America Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 36: North America Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 37: North America Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 38: North America Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 39: Europe Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 42: Europe Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 43: Europe Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 44: Europe Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 45: Europe Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 46: Europe Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 47: Europe Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 48: Europe Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 49: Europe Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 50: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 57: Asia Pacific Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 58: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 59: Asia Pacific Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 60: Asia Pacific Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 61: Latin America Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 64: Latin America Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 66: Latin America Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 67: Latin America Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 68: Latin America Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 69: Latin America Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 70: Latin America Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 71: Latin America Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 72: Middle East & Africa Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 75: Middle East and Africa Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 76: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 77: Middle East and Africa Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 78: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 79: Middle East and Africa Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 80: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 81: Middle East and Africa Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 82: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
目次
Product Code: TMRGL1779

Facial Injectables Market - Scope of Report

TMR's report on the global facial injectables market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global facial injectables market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global facial injectables market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the facial injectables market.

Market Snapshot
Market Value in 2024US$ 10.3 Bn
Market Value in 2035US$ 27 Bn
CAGR9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global facial injectables market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global facial injectables market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global facial injectables market.

The report delves into the competitive landscape of the global facial injectables market. Key players operating in the global facial injectables market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global facial injectables market profiled in this report.

Key Questions Answered in Global facial injectables market Report:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global facial injectables market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global facial injectables market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global facial injectables market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global facial injectables market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Facial Injectables Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
  • 5.2. Product/Brand Analysis
  • 5.3. Pricing Analysis
  • 5.4. Technological Advancements
  • 5.5. PESTEL Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Porter's Five Forces Analysis
  • 5.8. Reimbursement Scenario by Key Countries
  • 5.9. Key Purchase Metrics for End-users
  • 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Dermal Fillers
      • 6.3.1.1. Hyaluronic acid (HA)
      • 6.3.1.2. Calcium hydroxylapatite (CaHA)
      • 6.3.1.3. Poly-L-lactic acid (PLLA)
      • 6.3.1.4. Polymethylmethacrylate (PMMA)
      • 6.3.1.5. Others
    • 6.3.2. Botulinum Toxin
    • 6.3.3. Platelet-Rich Plasma (PRP)
    • 6.3.4. Deoxycholic Acid
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Gender

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Gender, 2020 to 2035
    • 7.3.1. Male
    • 7.3.2. Female
  • 7.4. Market Attractiveness Analysis, by Gender

8. Global Facial Injectables Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020 to 2035
    • 8.3.1. Facial Line Correction
    • 8.3.2. Lip Augmentation
    • 8.3.3. Scar Treatment
    • 8.3.4. Face Lift
    • 8.3.5. Facial Volume Enhancement
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Facial Injectables Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020 to 2035
    • 9.3.1. Hospitals
    • 9.3.2. Dermatology Clinics
    • 9.3.3. MedSpas
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Facial Injectables Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020 to 2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Facial Injectables Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Dermal Fillers
      • 11.2.1.1. Hyaluronic acid (HA)
      • 11.2.1.2. Calcium hydroxylapatite (CaHA)
      • 11.2.1.3. Poly-L-lactic acid (PLLA)
      • 11.2.1.4. Polymethylmethacrylate (PMMA)
      • 11.2.1.5. Others
    • 11.2.2. Botulinum Toxin
    • 11.2.3. Platelet-Rich Plasma (PRP)
    • 11.2.4. Deoxycholic Acid
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Gender, 2020 to 2035
    • 11.3.1. Male
    • 11.3.2. Female
  • 11.4. Market Value Forecast, by Application, 2020 to 2035
    • 11.4.1. Facial Line Correction
    • 11.4.2. Lip Augmentation
    • 11.4.3. Scar Treatment
    • 11.4.4. Face Lift
    • 11.4.5. Facial Volume Enhancement
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by End-user, 2020 to 2035
    • 11.5.1. Hospitals
    • 11.5.2. Dermatology Clinics
    • 11.5.3. MedSpas
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Gender
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Facial Injectables Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Dermal Fillers
      • 12.2.1.1. Hyaluronic acid (HA)
      • 12.2.1.2. Calcium hydroxylapatite (CaHA)
      • 12.2.1.3. Poly-L-lactic acid (PLLA)
      • 12.2.1.4. Polymethylmethacrylate (PMMA)
      • 12.2.1.5. Others
    • 12.2.2. Botulinum Toxin
    • 12.2.3. Platelet-Rich Plasma (PRP)
    • 12.2.4. Deoxycholic Acid
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Gender, 2020 to 2035
    • 12.3.1. Male
    • 12.3.2. Female
  • 12.4. Market Value Forecast, by Application, 2020 to 2035
    • 12.4.1. Facial Line Correction
    • 12.4.2. Lip Augmentation
    • 12.4.3. Scar Treatment
    • 12.4.4. Face Lift
    • 12.4.5. Facial Volume Enhancement
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by End-user, 2020 to 2035
    • 12.5.1. Hospitals
    • 12.5.2. Dermatology Clinics
    • 12.5.3. MedSpas
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Gender
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Facial Injectables Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Dermal Fillers
      • 13.2.1.1. Hyaluronic acid (HA)
      • 13.2.1.2. Calcium hydroxylapatite (CaHA)
      • 13.2.1.3. Poly-L-lactic acid (PLLA)
      • 13.2.1.4. Polymethylmethacrylate (PMMA)
      • 13.2.1.5. Others
    • 13.2.2. Botulinum Toxin
    • 13.2.3. Platelet-Rich Plasma (PRP)
    • 13.2.4. Deoxycholic Acid
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Gender, 2020 to 2035
    • 13.3.1. Male
    • 13.3.2. Female
  • 13.4. Market Value Forecast, by Application, 2020 to 2035
    • 13.4.1. Facial Line Correction
    • 13.4.2. Lip Augmentation
    • 13.4.3. Scar Treatment
    • 13.4.4. Face Lift
    • 13.4.5. Facial Volume Enhancement
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by End-user, 2020 to 2035
    • 13.5.1. Hospitals
    • 13.5.2. Dermatology Clinics
    • 13.5.3. MedSpas
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Gender
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Facial Injectables Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Dermal Fillers
      • 14.2.1.1. Hyaluronic acid (HA)
      • 14.2.1.2. Calcium hydroxylapatite (CaHA)
      • 14.2.1.3. Poly-L-lactic acid (PLLA)
      • 14.2.1.4. Polymethylmethacrylate (PMMA)
      • 14.2.1.5. Others
    • 14.2.2. Botulinum Toxin
    • 14.2.3. Platelet-Rich Plasma (PRP)
    • 14.2.4. Deoxycholic Acid
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Gender, 2020 to 2035
    • 14.3.1. Male
    • 14.3.2. Female
  • 14.4. Market Value Forecast, by Application, 2020 to 2035
    • 14.4.1. Facial Line Correction
    • 14.4.2. Lip Augmentation
    • 14.4.3. Scar Treatment
    • 14.4.4. Face Lift
    • 14.4.5. Facial Volume Enhancement
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by End-user, 2020 to 2035
    • 14.5.1. Hospitals
    • 14.5.2. Dermatology Clinics
    • 14.5.3. MedSpas
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Gender
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Facial Injectables Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 15.2.1. Dermal Fillers
      • 15.2.1.1. Hyaluronic acid (HA)
      • 15.2.1.2. Calcium hydroxylapatite (CaHA)
      • 15.2.1.3. Poly-L-lactic acid (PLLA)
      • 15.2.1.4. Polymethylmethacrylate (PMMA)
      • 15.2.1.5. Others
    • 15.2.2. Botulinum Toxin
    • 15.2.3. Platelet-Rich Plasma (PRP)
    • 15.2.4. Deoxycholic Acid
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Gender, 2020 to 2035
    • 15.3.1. Male
    • 15.3.2. Female
  • 15.4. Market Value Forecast, by Application, 2020 to 2035
    • 15.4.1. Facial Line Correction
    • 15.4.2. Lip Augmentation
    • 15.4.3. Scar Treatment
    • 15.4.4. Face Lift
    • 15.4.5. Facial Volume Enhancement
    • 15.4.6. Others
  • 15.5. Market Value Forecast, by End-user, 2020 to 2035
    • 15.5.1. Hospitals
    • 15.5.2. Dermatology Clinics
    • 15.5.3. MedSpas
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Gender
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. AbbVie Inc. (Allergan Aesthetics)
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Anika Therapeutics, Inc.
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Bioplus Co., Ltd.
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. BIOXIS Pharmaceuticals
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Bloomage Biotech Co., Ltd
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Galderma
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Sinclair Pharma
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Revance Therapeutics, Inc.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Merz Pharma GmbH & Co. KGaA
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Prollenium Medical Technologies Inc.
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Teoxane SA
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. Croma-Pharma GmbH
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Fidia Pharma USA Inc.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Tiger Aesthetics Medical, LLC
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments